probenecid has been researched along with Haemophilus influenzae Meningitis Type B in 3 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shann, F | 1 |
| Germer, S | 1 |
| Spector, R | 1 |
| Lorenzo, AV | 1 |
| Legler, F | 1 |
3 other studies available for probenecid and Haemophilus influenzae Meningitis Type B
| Article | Year |
|---|---|
Treatment of bacterial meningitis without intravenous fluids.
Topics: Chloramphenicol; Drug Therapy, Combination; Humans; Meningitis, Haemophilus; Penicillins; Probenecid | 1983 |
Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Cerebrospinal Fluid; Choroid Plexus; Cisterna M | 1974 |
[The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
Topics: Ampicillin; Biliary Tract Diseases; Escherichia coli Infections; Humans; Klebsiella Infections; Meni | 1966 |